Argentina- Fundación GEP opposed Gilead´s patent application on remdesivir
Fundación GEP has filed this week a patent opposition against Gilead patent application on remdesivir before Argentinean Patent Office. GEP has requested…
Latin American Network for Access to Medicines
Medicines for everyone, free from patent barriers and monopolies
RedLAM focuses its goals, strategies and actions on helping to remove the barriers to access to HIV medicines created by intellectual property rights and other exclusive rights.
Latest news · June 5, 2020Argentina- Fundación GEP opposed Gilead´s patent application on remdesivir
5countries and 6
organizations in the network
Campaigns
Campaign
Llamado a defender la licencia obligatoria de dolutegravir en Colombia
Sign-on letter (opens in a new tab) Sign the letter (opens in a new tab)
Statement
Declaración de Mar del Plata: el pueblo de Latinoamérica llama a la acción colectiva por el acceso a tecnologías sanitarias
Leer la declaración (opens in a new tab) Firmar la declaración (opens in a new tab)
Latest news
All newsMost of our news is published in Spanish: your browser can translate it for you.
REDLAM IN GENEVA: A WEEK OF ACTION AGAINST CORPORATE POWER AND FOR THE SOVEREIGNTY OF PEOPLE
Between October 12th and 19th, RedLAM is in Geneva participating of the “Week of Peoples”, a wake up call to social movements worldwide to contribute to the…
AIDS film festival expands debate on access to medicines and strengthens role of civil society
Río de Janeiro, September 10th, 2015 – On August 31st (Rio de Janeiro) and December 2nd (Sao Paulo) a special edition of the AIDS Film Festival took place…
FGEP discussed access to medicines at the ‘Encuentro Nacional de Equipos de Salud’
FGEP´s Executive Director, Mrs Lorena Di Giano, participated at the Debate Panel on Medicines’ Public Policies, along with representatives of the Ministry…
